Anti-cancer Drugs Associated Atrial Fibrillation—An Analysis of Real-World Pharmacovigilance Data

BACKGROUND: Several anti-cancer drugs have been linked to new onset atrial fibrillation (AF) but the true association of these drugs with AF is unknown. The FDA Adverse Event Reporting System (FAERS), a publicly available pharmacovigilance mechanism provided by the FDA, collects adverse event report...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Javaria, Thurlapati, Aswani, Thotamgari, Sahith, Grewal, Udhayvir Singh, Sheth, Aakash Rajendra, Gupta, Dipti, Beedupalli, Kavitha, Dominic, Paari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051026/
https://www.ncbi.nlm.nih.gov/pubmed/35498039
http://dx.doi.org/10.3389/fcvm.2022.739044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051026/
https://www.ncbi.nlm.nih.gov/pubmed/35498039
http://dx.doi.org/10.3389/fcvm.2022.739044

Ejemplares similares